ANASTROZOL · 1 MG · 60 TABLETAS | Control Estrogénico. Físico Definido.

Key Benefits of Anastrozole Aromatase Inhibition and Estradiol Reduction Anastrozole is a third-generation non-steroidal aromatase inhibitor that acts by blocking the aromatase enzyme, responsible for converting androgens (such as testosterone) into estrogens. By inhibiting this enzyme, anastrozole significantly reduces blood estradiol levels, the most potent form of estrogen. Gynecomastia Prevention By blocking testosterone-to-estrogen conversion, anastrozole prevents gynecomastia (breast tissue growth in men) development, one of the most feared side effects of aromatizable anabolic steroid use. Fluid Retention Reduction Anastrozole reduces subcutaneous fluid retention caused by elevated estrogen levels. By reducing fluid retention, muscle appears drier, harder, and more vascular, improving physical aesthetics. Greater Muscle Definition and Vascularity By reducing fluid retention and controlling estrogen levels, anastrozole contributes to a drier, more defined appearance. Reduction of subcutaneous fat and fluid retention reveals underlying musculature, improving definition and vascularity. Estrogenic Side Effect Control Anastrozole helps prevent symptoms of high estrogen levels such as decreased libido, erectile dysfunction, muscle mass loss, fatigue, and mood changes . Hormonal Axis Suppression Prevention By controlling estrogen levels, anastrozole may help prevent hypothalamic-pituitary-gonadal (HPA) axis suppression associated with elevated estrogen levels.

Function and Mechanism of Action of Anastrozole Anastrozole is a third-generation non-steroidal aromatase inhibitor. Its chemical name is 1,3-benzenediacetonitrile, α,α,α&amp;#039;,α&amp;#039;-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl). It was originally developed for breast cancer treatment in postmenopausal women and has been adapted for estrogen control use in the sports context. Detailed Mechanism of Action: Aromatase Enzyme Inhibition: Anastrozole binds to the active site of the aromatase enzyme (CYP19A1), a cytochrome P450 that catalyzes androgen-to-estrogen conversion. Binding is competitive and reversible, allowing precise estrogen level control. By blocking aromatase, anastrozole reduces estradiol production from testosterone and androstenedione. Estradiol Reduction: Aromatase inhibition results in a significant decrease in blood estradiol levels. In clinical studies, anastrozole has demonstrated estradiol level reduction of over 80% in postmenopausal women. Effect on the Hormonal Axis: By reducing estradiol levels, anastrozole eliminates the negative feedback that estrogen exerts on the hypothalamic-pituitary-gonadal (HPG) axis. This can result in a compensatory increase in LH and FSH, which in turn stimulates testosterone production in the testes. Adipose and Breast Tissue Selectivity: Anastrozole has high selectivity for adipose and breast tissue, where aromatase is most active. This allows precise estrogen level control in tissues where androgen-to-estrogen conversion is most significant. Comparison with Other Aromatase Inhibitors: Anastrozole is more selective and potent than first-generation inhibitors such as aminoglutethimide. It is comparable to letrozole and exemestane in terms of efficacy, but has a different side effect profile.

How to Use Anastrozole Route of Administration: Oral. Anastrozole is administered as tablets for oral ingestion. Tablets should be swallowed whole with water. Dosage: Dosage should be determined by a physician according to indications and patient condition. General dosage guidelines for anastrozole include: Estrogen Control during Steroid Cycles: 0.25-1 mg per day or every other day, depending on steroid dosage and individual response. Initial Dose: 0.5 mg every other day, adjusting according to estradiol levels and symptoms. Maintenance Dose: 0.25-0.5 mg every other day or 0.5-1 mg every 3-4 days . Frequency: Daily or every other day administration. Anastrozole has a half-life of approximately 50 hours, allowing less frequent administration. Treatment Duration: Depends on steroid cycle duration. Use during the cycle is recommended, adjusting according to estradiol levels and symptoms. Prolonged use without aromatizable steroids is not recommended. Storage: Store in a cool, dry place, protected from light and at controlled temperature (2-8°C). Keep out of reach of children. Important Notice: Product intended FOR HUMAN USE under medical supervision. Anastrozole is a prescription medication and its use must be supervised by a physician. Excessive use can excessively reduce estrogen levels, causing adverse effects such as joint dryness, libido loss, dyslipidemia, and osteoporosis. Not recommended without aromatizable steroids

Ingredients of Anastrozole Active Ingredient: Anastrozole: A third-generation non-steroidal aromatase inhibitor that acts by blocking the aromatase enzyme . Used for estrogen control during steroid cycles. Molecular formula: C₁₇H₁₉N₅. Molecular weight: 293.37 g/mol. CAS: 120511-73-1. Excipients: Each 1 mg tablet contains the following excipients (according to standard anastrozole formulations): Lactose monohydrate: Used as an excipient and bulking agent. Microcrystalline cellulose: Used as a bulking agent and disintegrant. Corn starch: Used as a disintegrant and bulking agent. Magnesium stearate: Used as a lubricant. Colloidal anhydrous silica: Used as a flow agent. Note: Specific excipients may vary by manufacturer. Consult the product leaflet for the complete list of excipients. Note for Users: This product is a pharmaceutical-grade medication manufactured under strict quality control standards (GMP) by Kinetix Pharma, in the Czech Republic. Each package contains 60 tablets of 1 mg each.

Onset Time &amp;amp; Expected Results of Anastrozole Onset of Action (Hours to Days): Anastrozole begins acting within the first hours after oral administration. Effects on estradiol levels are observed within the first days of treatment. The half-life of approximately 50 hours allows for rapid onset of action and sustained effects. Measurable Benefits (1-2 Weeks): The first measurable changes in estradiol levels and fluid retention reduction begin to be visible within the first 1-2 weeks of consistent use. Users report decreased fluid retention and a drier appearance. Full Effect (2-4 Weeks): For complete estrogen level control and maximum definition, the full effect often requires 2-4 weeks of consistent use. Anastrozole can reduce estradiol levels by over 80% in postmenopausal women. Factors Influencing Results: The speed and magnitude of results depend on dose administered, administration frequency, adherence to the treatment protocol, aromatizable steroid dosage, and individual metabolism.

Clinical Research &amp;amp; 3rd Party Test Results of Anastrozole Scientific evidence on anastrozole comes from decades of medical use and clinical studies in breast cancer treatment, as well as experience in the sports context. Clinical Evidence in Humans: Aromatase Inhibition: Anastrozole is a third-generation non-steroidal aromatase inhibitor that acts by blocking the aromatase enzyme . In clinical studies, it has demonstrated estradiol level reduction of over 80% in postmenopausal women. Efficacy in Estrogen Control: Anastrozole has proven effective in controlling estrogen levels in the sports context, preventing gynecomastia and fluid retention . Effects on Lipid Profile: Anastrozole may have adverse effects on lipid profile, reducing HDL cholesterol and increasing LDL in some patients. Lipid level monitoring during use is recommended. Effects on Bone Density: Prolonged anastrozole use may reduce bone density due to decreased estrogen levels, which are important for bone health. Safety Considerations: Common Side Effects: Hot flashes, joint pain, weakness, fatigue, and mood changes . Serious Side Effects: Bone density reduction, osteoporosis, dyslipidemia, and adverse cardiovascular effects . Contraindications: Hypersensitivity to anastrozole, pregnancy, and breastfeeding. Regulatory Status: Anastrozole is a prescription medication. Kinetix Pharma Quality Standards: Pharmaceutical Grade: Pharmaceutical-grade medication for human use. Manufacturing: Manufactured in the Czech Republic under strict GMP standards by Kinetix Pharma. Quality Control: Each batch is subjected to quality control testing to ensure purity and potency.

Product Details

ANASTROZOL · 1 MG · 60 TABLETAS | Control Estrogénico. Físico Definido.

ANASTROZOL · 1 MG · 60 TABLETAS | Control Estrogénico. Físico Definido.

Build Your Stack

Frequently Asked Questions